Validity of pathological diagnosis for early colorectal cancer in genetic background

This study aimed to investigate the validity of pathological diagnosis of early CRC (E‐CRC) from the genetic background by comparing data of E‐CRC to colorectal adenoma (CRA) and The Cancer Genome Atlas (TCGA) on advanced CRC (AD‐CRC).

[1]  Yang Xu,et al.  Comprehensive genomic profiling of colorectal cancer patients reveals differences in mutational landscapes among clinical and pathological subgroups , 2022, Frontiers in Oncology.

[2]  M. Karin,et al.  Immunotherapy, Inflammation and Colorectal Cancer , 2020, Cells.

[3]  M. Omata,et al.  Deficiency of mismatch repair genes is less frequently observed in signet ring cell compared with non-signet ring cell gastric cancer , 2019, Medical Oncology.

[4]  M. Omata,et al.  Molecular subtype switching in early-stage gastric cancers with multiple occurrences , 2019, Journal of Gastroenterology.

[5]  M. Omata,et al.  Distribution of circulating tumor DNA in lung cancer: analysis of the primary lung and bone marrow along with the pulmonary venous and peripheral blood , 2017, Oncotarget.

[6]  Teruhiko Yoshida,et al.  Mismatch repair deficiency commonly precedes adenoma formation in Lynch Syndrome-Associated colorectal tumorigenesis , 2017, Modern Pathology.

[7]  Moriah H Nissan,et al.  OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.

[8]  H. Clevers,et al.  RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation , 2016, Gut.

[9]  T. Ushijima,et al.  Frequent PTPRK–RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma , 2016, The Journal of pathology.

[10]  M. Omata,et al.  Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer , 2015, Molecular genetics & genomic medicine.

[11]  T. Yamanaka,et al.  A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer , 2015, BMC Cancer.

[12]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[13]  Kristian Cibulskis,et al.  RNF43 is frequently mutated in colorectal and endometrial cancers , 2014, Nature Genetics.

[14]  A. Bouchard-Côté,et al.  PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.

[15]  W. de Lau,et al.  The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength , 2014, Genes & development.

[16]  H. Ashktorab,et al.  BMI and the risk of colorectal adenoma in African Americans , 2014, Obesity.

[17]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[18]  G. Millington.  Mutations of the BRAF gene in human cancer, by Davies et al. (Nature 2002; 417: 949–54) , 2013, Clinical and experimental dermatology.

[19]  Peter Donnelly,et al.  Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2012, Nature Genetics.

[20]  H. Clevers,et al.  Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors , 2012, Nature.

[21]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[22]  A. Zauber,et al.  Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. , 2012, The New England journal of medicine.

[23]  Meng Li,et al.  Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types , 2011, Human mutation.

[24]  João Niza,et al.  Neuroendocrine neoplasms of the pancreas: clinical, pathologic and cross-sectional imaging analysis according to the 4 th edition of the World Health Organization (WHO) classification of tumors of the digestive system , 2012 .

[25]  Y. Yatabe,et al.  BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer , 2011, British Journal of Cancer.

[26]  L. Terracciano,et al.  Clinicopathological and protein characterization of BRAF‐ and K‐RAS‐mutated colorectal cancer and implications for prognosis , 2010, International journal of cancer.

[27]  T. Tuohy,et al.  Hereditary and familial colon cancer. , 2010, Gastroenterology.

[28]  E. Giovannucci,et al.  Primary prevention of colorectal cancer. , 2010, Gastroenterology.

[29]  J. Potter,et al.  Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. , 2009, Gastroenterology.

[30]  B. Park,et al.  Knockin of mutant PIK3CA activates multiple oncogenic pathways , 2009, Proceedings of the National Academy of Sciences.

[31]  Christopher F. Martin,et al.  Dietary Patterns and Colon Cancer Risk in Whites and African Americans in the North Carolina Colon Cancer Study , 2009, Nutrition and cancer.

[32]  A. Sweet-Cordero,et al.  Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon , 2008, Nature Genetics.

[33]  R. Hamelin,et al.  Assessment of MLH1 promoter methylation in relation to gene expression requires specific analysis , 2007, Oncogene.

[34]  María Elena Martínez,et al.  Primary prevention of colorectal cancer: lifestyle, nutrition, exercise. , 2005, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[35]  P. Peltomäki,et al.  Mutations Associated with HNPCC Predisposition — Update of ICG-HNPCC/INSiGHT Mutation Database , 2004, Disease markers.

[36]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[37]  H. Lynch,et al.  GENETIC SUSCEPTIBILITY TO NONPOLYPOSIS COLORECTAL CANCER , 1999 .

[38]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[39]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[40]  G. Miller.  Carcinoma of the Colon and Rectum. , 1942, Canadian Medical Association journal.